Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Merck And Co Inc's Business Segments

Merck And Co Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q2 FY2026
Reportable Segments
3
Per the company's own filing, this quarter
Largest Segment
Pharmaceutical segment
88.9% of revenue
Total Revenue
$ 16,607
Consolidated, this quarter
Regions Reported
5
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/MRK/segments
https://api.csimarket.com/api/v1/companies/MRK/geographic
https://api.csimarket.com/api/v1/companies/MRK/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q2 FY2026

89%largest
  • Pharmaceutical segment88.9%
  • Animal Health segment10.7%
  • Corporate and Unallocated0.4%

Revenue by Reportable Segment - Q2 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Pharmaceutical segmentQ2 FY2026$ 14,76088.9%-
Animal Health segmentQ2 FY2026$ 1,77510.7%-
Corporate and UnallocatedQ2 FY2026$ 720.4%-

Revenue Share by Region - Q2 FY2026

24%largest
  • EMEA23.6%
  • Latin America5.3%
  • Asia Pacific4.9%
  • Other Countries3.9%
  • Non-US0.4%

Revenue by Geographic Region - Q2 FY2026

RegionPeriodRevenue
(Millions)
% of Total
EMEAQ2 FY2026$ 3,92023.6%
Latin AmericaQ2 FY2026$ 8755.3%
Asia PacificQ2 FY2026$ 8204.9%
2 more regions available

Sign in to unlock the full Merck And Co Inc dataset.

Revenue by Product & Service Category - Q2 FY2026

48%largest
  • Keytruda47.6%
  • Gardasil/Gardasil 97%
  • Livestock6.3%
  • Companion Animal4.4%
  • Other Pharmaceutical3.9%
  • ProQuad MMR II Varivax3.6%
  • Winrevair3.5%
  • Bridion3%
  • Keytruda Qlex2.8%
  • Alliance revenue - Lynparza2.2%
  • Prevymis1.8%
  • Lenvima1.7%
  • Welireg1.6%
  • Januvia1.6%
  • Ohtuvayre1.2%
  • Capvaxive1.1%
  • Janumet1%
  • Vaxneuvance0.9%
  • Rotateq0.8%
  • Alliance revenue - Adempas/Verquvo0.8%
  • Alliance Revenue - Reblozyl0.7%
  • Delstrigo0.6%
  • Adempas0.5%
  • Zerbaxa0.5%
  • Isentress/Isentress HD0.4%
  • Dificid0.1%
  • Alliance revenue - Koselugo0.1%
  • Lagevrio0%

Revenue by Product & Service Category - Q2 FY2026

CategoryPeriodRevenue
(Millions)
% of Total
KeytrudaQ2 FY2026$ 7,90447.6%
Gardasil/Gardasil 9Q2 FY2026$ 1,1697%
LivestockQ2 FY2026$ 1,0416.3%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

25 more categories available

Sign in to unlock the full Merck And Co Inc dataset.

Description of Merck And Co Inc's Business Segments

Merck & Co. Inc.: Company Overview

Merck & Co. Inc. known as Merck, is a prominent global pharmaceutical company that focuses on research-driven development, manufacturing, and marketing of a diverse range of innovative health solutions aimed at improving both human and animal health. Established in 1891, with headquarters in Kenilworth, New Jersey, Merck has positioned itself as a leader in the pharmaceutical industry by emphasizing scientific innovation, product efficacy, safety, and value.

Core Operations and Product Offerings

Merck operates across various therapeutic areas, offering an extensive portfolio that includes both therapeutic and preventive products primarily sold through prescriptions. The companys products address numerous medical conditions and health needs, reflecting its commitment to enhancing health outcomes. Some key therapeutic categories include:

1. Cardiovascular Health: Mercks cardiovascular lineup includes treatments for atherosclerosis and hypertension. Zocor (simvastatin) has historically been one of the best-selling medications in this category, along with Cozaar (losartan potassium) and Vasotec (enalapril maleate), which are essential for managing hypertension and heart failure.

2. Anti-Inflammatory and Analgesic Medications: The company has made significant contributions to pain management with its COX-2 inhibitors like Vioxx (rofecoxib) and Arcoxia (etoricoxib), which target pain and inflammation with specific mechanisms of action.

3. Osteoporosis Treatments: Fosamax (alendronate sodium) is a flagship product that aids in the treatment and prevention of osteoporosis, making it a vital option for those at risk.

4. Respiratory Health: Singulair (montelukast sodium) is specifically designed for asthma treatment and relief of seasonal allergic rhinitis symptoms, further showcasing Mercks commitment to managing chronic respiratory conditions.

5. Vaccines and Biologicals: Merck has been a leader in vaccine development. Key products include M-M-R II (measles, mumps, and rubella virus vaccine), Varivax (chickenpox vaccine), and Recombivax HB (hepatitis B vaccine), which play crucial roles in preventive health care.

6. Antibacterial and Antifungal Treatments: The company markets several products for infectious diseases, including Primaxin (imipenem and cilastatin sodium), Cancidas (caspofungin acetate), and Invanz (ertapenem sodium), which are vital in combating serious infections.

Ophthalmological Products: Merck offers Cosopt (dorzolamide and timolol ophthalmic solution) and Trusopt (dorzolamide hydrochloride) for managing intraocular pressure in patients with glaucoma.

8. Urology Products: Proscar (finasteride) exemplifies Mercks focus on improving the quality of life for men with benign prostatic hyperplasia.

9. HIV Treatments: Mercks efforts in HIV treatment include significant products such as Crixivan (indinavir sulfate) and Stocrin (efavirenz), which are foundational in HIV therapy regimens.

10. Other Products: The companys portfolio also features treatments for conditions like acute migraines (Maxalt), male pattern baldness (Propecia), and various medications that enhance the therapeutic landscape.

Business Model and Market Approach

Mercks business model is centered around direct and indirect sales to a wide array of healthcare providers such as drug wholesalers, retailers, hospitals, clinics, and government agencies. The company expertly navigates the complexities of the healthcare landscape, ensuring that healthcare professionals are well-informed about the effectiveness and safety of their offerings through continuous communication and education efforts.

Competitive Landscape and Challenges

The pharmaceutical market is highly competitive and heavily regulated. Merck competes with numerous pharmaceutical companies globally, driving a race for technological innovations and effective marketing strategies. To maintain its market position, Merck invests substantially in research and development, leading to the discovery of new compounds that can address unmet medical needs. The company actively seeks strategic partnerships, joint ventures, and acquisitions to bolster its product portfolio and enhance its competitive edge.

Despite the robust capabilities and extensive product range, Merck faces challenges related to price pressures due to healthcare cost containment efforts, evolving regulatory landscapes, and the potential for market saturation as more compounds become available for treating specific diseases. Competitor advancements can lead to the introduction of new products that may outperform existing therapies, requiring Merck to adapt continuously.

Commitment to Healthcare Improvement

At its core, Merck is dedicated to preserving and enhancing human life and animal health. The companys mission emphasizes the importance of patient-centric healthcare, striving to meet the evolving needs of both healthcare professionals and consumers. Merck stands by its commitment to high professional standards, aiming to provide exemplary health delivery systems and innovative solutions that align with the dynamic demands of the healthcare environment.

Overall, Merck & Co. Inc. remains a stalwart in the pharmaceutical industry, exemplifying a blend of scientific innovation, strategic market engagement, and a clear focus on improving lives through healthcare excellence. The companys innovative spirit and scientific rigor continue to pave the way for advancements that address the pressing health challenges of today and the future.
As of October 2023, Merck & Co. Inc. remains a global leader in pharmaceuticals and healthcare, providing a wide array of products and services across various segments. The influence of Mercks innovation continues to impact both human and animal health significantly. Below is a detailed overview of the companys business segments, products, and related services:

1. Pharmaceuticals

The pharmaceutical segment constitutes the backbone of Mercks operations, emphasizing the discovery, development, manufacturing, and marketing of therapeutic and preventive agents, which are primarily available by prescription. Key therapeutic areas include:

a. Bone, Respiratory, Immunology, and Dermatology
- Singulair (Montelukast): A leukotriene receptor antagonist used for managing asthma and allergic rhinitis.
- Remicade (Infliximab): A monoclonal antibody utilized for the treatment of autoimmune diseases, including rheumatoid arthritis, Crohns disease, and ulcerative colitis.
- Fosamax (Alendronate): Prescribed for the treatment of osteoporosis and related conditions.
- Nasonex (Mometasone): A nasal spray effective in treating allergic rhinitis and nasal polyps.
- Propecia (Finasteride): Approved for the treatment of male pattern baldness.
- Clarinex (Desloratadine): An antihistamine offering relief from allergies without causing drowsiness.
- Arcoxia (Etoricoxib): A cyclooxygenase-2 inhibitor used for pain and inflammation.
- Asmanex Twisthaler (Mometasone furoate): An inhaled corticosteroid targeting asthma management.

b. Cardiovascular Diseases
- Zetia (Ezetimibe): A cholesterol-lowering medication that reduces cholesterol absorption in the intestine.
- Vytorin (Ezetimibe/Simvastatin): Combines cholesterol absorption inhibition with statin therapy to address dyslipidemia.
- Integrilin (Eptifibatide Injection): A GP IIb/IIIa inhibitor utilized in managing acute coronary syndrome.

c. Diabetes and Obesity
- Januvia (Sitagliptin): A DPP-4 inhibitor used for managing type 2 diabetes.
- Janumet (Sitagliptin/Metformin): A combination medication providing dual action for glucose regulation in diabetes management.

d. Infectious Diseases
- Isentress (Raltegravir): An essential antiretroviral for managing HIV infections.
- Primaxin (Imipenem/Cilastatin): A broad-spectrum antibiotic effective against serious infections.
- Cancidas (Caspofungin acetate): Targeted treatment for invasive fungal infections.
- Avelox (Moxifloxacin): An antibiotic prescribed for bacterial infections.

e. Mature Brands
- Cozaar (Losartan): An angiotensin receptor blocker for managing hypertension.
- Zocor (Simvastatin): A cholesterol management statin.
- Proventil HFA (Albuterol): An inhalation aerosol providing relief for bronchospasm.

f. Neurosciences and Ophthalmology
- Maxalt (Rizatriptan): Utilized for acute migraine attacks.
- Remeron (Mirtazapine): An antidepressant effective in managing major depressive disorders.
- Cosopt/Trusopt: Ophthalmic solutions aimed at controlling intraocular pressure in glaucoma patients.

g. Oncology
- Temodar (Temozolomide): Prescribed for the treatment of brain tumors and certain cancers.
- Emend (Aprepitant): Effective in preventing chemotherapy-induced nausea and vomiting.

h. Vaccines
- Gardasil: A prominent vaccine for the prevention of human papillomavirus (HPV).
- Pneumovax: A pneumococcal vaccine aimed at preventing pneumonia and other diseases caused by pneumococcal bacteria.
- ProQuad: A combination vaccine protecting against measles, mumps, rubella, and varicella (chickenpox).

i. Women’s Health
- Follistim/Puregon: Medications developed for fertility treatments.
- NuvaRing (Etonogestrel/Ethinyl Estradiol): A contraceptive vaginal ring.

Animal Health

Mercks Animal Health division centers on preventing and treating diseases in various animal populations, including livestock, poultry, and companion animals. The key offerings include:

a. Livestock Products
- Nuflor: An antibiotic specifically utilized for treating bacterial infections in cattle and swine.
- Bovilis/Vista: A range of vaccines aimed at addressing infectious diseases affecting livestock.
- Porcilis: Focused vaccination solutions designed for swine.

b. Poultry Products
- Nobilis/Innovax: A series of vaccines aimed at combating poultry diseases, ensuring animal welfare and food safety.

c. Companion Animal Products
- Nobivac: Vaccines specifically designed for cats and dogs to guard against various contagious diseases.
- Caninsulin/Vetsulin: Insulin formulations catering to diabetic pets, enabling better disease management.

d. Aquaculture Products
- Aquaflor: An antibiotic used in aquaculture settings to control bacterial infections in fish populations.

Consumer Health Care

Merck offers a diverse range of consumer health products focused on over-the-counter (OTC) medications, foot care, and sun care, addressing health concerns in everyday consumer markets.

a. OTC Products
- Claritin: A well-known non-drowsy antihistamine used for allergy relief.
- MiraLAX: An agent for managing occasional constipation.
- Afrin: A nasal decongestant providing relief from nasal congestion.

b. Foot Care
- Dr. Scholl’s: A product line including orthotic insoles and foot care solutions addressing various foot health issues.

c. Sun Care
- Coppertone: A leading brand of sun protection products, including lotions and sprays to protect skin from harmful UV rays.
- Solarcaine: A line of products formulated for relief from sunburn.

Summary

Merck & Co. Inc. continues to demonstrate profound commitment to innovation and improvement in health outcomes across its diverse segments. The company’s extensive portfolio addresses critical health needs worldwide, ensuring their position as a vital player in modern healthcare. Their ongoing research and investment in new therapies highlight their dedication to enhancing global health and well-being.